Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000242 · ClinicalTrials.gov registry record · Phase 2

Carbamazepine Treatment of Cocaine Dependence - 1

A Phase 2 study, sponsored by Medical University of South Carolina.

Completed
Registry status
Phase 2
Development phase

NCT00000242 is a Phase 2 study that has completed, run by Medical University of South Carolina.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000242, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
Phase 2
Development phase

Study Summary

The purpose of this study is to compare the efficacy of carbamazepine in treatment of cocaine-dependence in patients with affective disorders.

Interventions

  • DRUG Carbamazepine

Trial Details

FieldValue
Start Date 1992-10-01
Est. Completion 1997-01-25
Phase Phase 2

What the Registry Record Tells You About NCT00000242

The ClinicalTrials.gov registry entry for NCT00000242 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Carbamazepine is the first listed.

NCT00000242 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00000242 about?

NCT00000242 is a clinical study titled "Carbamazepine Treatment of Cocaine Dependence - 1". The purpose of this study is to compare the efficacy of carbamazepine in treatment of cocaine-dependence in patients with affective disorders.

What is the current status of trial NCT00000242?

This trial is currently completed. It is a Phase 2 study. The study started on 1992-10-01. Estimated completion is 1997-01-25.

What interventions are being tested in trial NCT00000242?

The interventions under investigation include: Carbamazepine (DRUG).

Who is sponsoring clinical trial NCT00000242?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.